SUMMARY

European Wax Center (EWCZ) signed definitive merger agreement Feb 9 for General Atlantic to take the company private at $5.80/share cash. Stock currently trading at $4.00 - a 45% spread to deal price.

This is either:

  1. Market hasn't reacted yet (8-K just filed), or
  2. Serious deal-break risk priced in

Committed financing in place ($74M debt from HPS, $110M equity from GA). Special Committee unanimously approved with Moelis fairness opinion. Reverse breakup fee ($19M) is 2.9x the company fee ($6.6M), signaling GA commitment.

Key risk insight: Deal requires TWO voting hurdles, not one. GA's 42% stake counts toward the first hurdle (majority of all shares) but not the second (majority-of-minority). The first hurdle is nearly locked (GA + 8% = pass). The entire deal risk concentrates in the second vote.

DEAL STRUCTURE

Parties:

  • Buyer: Glow Midco LLC (General Atlantic vehicle)
  • Target: EWCZ Class A shareholders (excluding GA affiliates)
  • Price: $5.80/share cash (≈$330M implied equity value)
  • Premium: 45% to Feb 9 close ($4.00)

Financing (committed):

  • Debt: $74M from HPS Investment Partners
  • Equity: $110M from GA Partners 100 LP
  • Status: Letters signed, customary closing conditions

Timeline:

  • Signed: Feb 9, 2026
  • Termination date: Aug 9, 2026 (≈6 months)
  • Expected close: Mid-2026

Breakup fees:

  • Company fee: $6.6M (if terminates for superior proposal)
  • Reverse fee: $19M (if GA fails to close)
  • Ratio: 2.9x reverse/company (strong signal)

APPROVAL STRUCTURE - DUAL VOTING MECHANICS

This is a controlling-shareholder freeze-out. GA already owns ≈42% and is buying out minorities. Delaware law (Kahn v. MFW) requires:

  1. ✓ Special Committee of independent directors
  2. ✓ Majority-of-minority vote (disinterested shareholders only)

Both conditions present. Special Committee:

  • Retained Moelis & Company as financial advisor
  • Received fairness opinion that $5.80 is fair
  • Unanimously approved and recommended deal

Full board also approved unanimously.

Critical voting mechanics (8-K lines 166-171):

Deal requires TWO votes, BOTH must pass:

(i) Majority of ALL outstanding Class A shares

  • GA's 42% stake COUNTS toward this hurdle
  • Math: 42% (GA) + 8% (others) = 50.1% → PASS
  • This hurdle is nearly guaranteed

(ii) Majority of disinterested stockholders

  • GA's 42% stake EXCLUDED from this vote
  • Only the ≈58% unaffiliated shareholders vote
  • Need >29% of total shares (>50% of the 58%) to approve
  • This is the SOLE real risk

Risk concentration: Because GA controls 42%, condition (i) is essentially locked. The entire deal outcome hinges on condition (ii) - whether the minority shareholders approve.

Why this matters: The 45% spread is pricing risk of the SECOND vote failing, not general deal uncertainty. If you believe minorities will approve, the first hurdle is free.

VALUATION CONTEXT

Deal price vs history:

  • Current: $4.00
  • Deal price: $5.80 (+45%)
  • 52-week high: $7.60 (deal is -24% below peak)
  • 52-week low: $2.72

Multiples at $5.80:

  • Forward P/E: ≈11x (vs 7.2x current)
  • Stock down -42% YTD before announcement

Analyst targets before deal:

  • Mean: $6.64
  • Median: $5.25
  • Range: $3.75-$15.00

Deal price ($5.80) sits between median analyst target and mean, but well below the 52-week high. This creates ammunition for shareholder lawsuits arguing price is opportunistically low.

OPERATIONAL PERFORMANCE

Earnings beats (last 4 quarters):

  • Q4 2024: $0.17 vs $0.06 est (+187%)
  • Q1 2025: $0.13 vs $0.05 est (+146%)
  • Q2 2025: $0.18 vs $0.16 est (+12%)
  • Q3 2025: $0.16 vs $0.10 est (+60%)

Average surprise: +101%

Consistent operational outperformance strengthens the bear case on deal price - if company is beating estimates by 101% on average, why accept a price 24% below 52-week high?

OPTIONS MARKET (ASLEEP)

ATM IV: 0.2% (-46th percentile vs 52-week range)

This is absurdly cheap for a stock with a definitive merger agreement and 45% spread to deal price. Either:

  1. Options market hasn't incorporated the event yet, or
  2. Market makers assume deal fails spectacularly

P/C ratio: 0.03 (30.8x more calls than puts by OI) But the strikes are wrong - massive OI at $2 strike (deep ITM), almost nothing near $5.80 deal price.

Verdict: Options market appears completely unaware of merger agreement.

WHAT SHOULD HAPPEN VS WHAT IS HAPPENING

Typical take-private mechanics:

  1. Definitive agreement signed
  2. Stock gaps to deal price minus time-value discount
  3. Spread narrows to 2-5% for 6-month close
  4. Arb funds accumulate

What's happening here:

  1. Definitive agreement signed ✓
  2. Stock still at $4.00 (45% below deal) ✗
  3. Options IV at 0.2% (market unaware) ✗
  4. Volume below average (0.6x 3-mo avg) ✗

Two interpretations:

A. Market lag - Filing dropped Feb 10, after-hours may not have digested yet. Stock could gap toward $5.50+ when market opens and processes the news.

B. Deal skepticism - Market is pricing significant probability that majority-of-minority vote fails. The 45% spread implies doubt about completion.

DEAL RISK ANALYSIS (REVISED)

Why it closes:

  1. Committed financing - $74M debt + $110M equity, signed commitments
  2. Special Committee process - Moelis fairness opinion, unanimous approval
  3. Reverse breakup fee - $19M (2.9x company fee) signals GA seriousness
  4. Limited guarantee - GA Partners 100 LP personally guaranteed reverse fee
  5. Kahn v. MFW satisfied - Both conditions (Special Committee + minority vote) present
  6. Strategic buyer - GA is existing ≈42% holder, knows the business, not opportunistic bid
  7. First voting hurdle nearly locked - GA's 42% + 8% others = guaranteed pass on condition (i)

Why it breaks:

  1. Majority-of-minority vote is sole gating risk - Need >50% of unaffiliated 58% to approve
  2. Price 24% below 52-week high - Shareholders may view as lowball
  3. Operational strength - 4/4 earnings beats, +101% avg surprise suggests upside
  4. Litigation risk - Freeze-outs attract lawsuits arguing inadequate price
  5. Superior proposal - Special Committee has fiduciary out (though no-shop standard)

Key insight from dual-vote structure:

Because GA's 42% guarantees condition (i) passes (only need 8% more), the ENTIRE deal outcome depends on condition (ii). This is not a "general deal risk" situation - it's a pure minority approval question.

The 45% spread is the market's estimate of P(minority rejects) × downside. If you believe Special Committee process was credible and price is fair (even if not generous), the spread is too wide.

Historical context: Controlling-shareholder freeze-outs with proper MFW process have high completion rates (>80%) when Special Committee approves. The dual-vote structure here actually REDUCES risk vs single-vote MOM deals, because GA's votes help with the first hurdle.

MERGER ARB MATH (REVISED)

If you believe deal closes:

Buy at: $4.00 Receive at close: $5.80 Gross return: 45% Time to close: ≈6 months (Aug 9 termination) Annualized return: ≈90%

Risks:

  • Deal breaks → stock likely returns to pre-announcement $4.00, or lower if thesis was purely deal-driven
  • Time risk → if close delayed, annualized return compresses
  • Opportunity cost → capital locked for 6 months

Break-even probability: If deal breaks and stock falls to $3.00 (-25%):

  • Gain if closes: +$1.80
  • Loss if breaks: -$1.00
  • Break-even P(close) = 36%

Meaning: If you believe >36% probability deal closes, positive EV.

Market's implied probability (revised analysis):

The dual-vote structure means we should decompose:

  • P(condition i passes) ≈ 95% (GA's 42% + need only 8% more)
  • P(condition ii passes | i passed) = X (the unknown)
  • P(deal closes) = 0.95 × X

If fair spread for 6-month close is 5%:

  • Fair price = $5.80 × 0.95 = $5.51
  • Actual price = $4.00
  • Implied P(deal closes) ≈ 50-60%
  • Backed out P(condition ii passes) ≈ 53-63%

Market is pricing 40-47% chance minorities reject. This seems high given:

  • Special Committee unanimous approval
  • Moelis fairness opinion
  • 45% premium to pre-deal price
  • GA committed financing and reverse breakup fee

The arb opportunity exists IF you believe minority rejection probability is <30% (not 40-47%).

WHAT TO WATCH

Immediate (next 2-3 days):

  1. Stock reaction - Does EWCZ gap toward $5.50+ when market digests the 8-K?
  2. Volume - Does arb community accumulate? (Watch for 3x+ avg volume)
  3. Options IV - Does ATM IV reprice from 0.2% to 40-60%?

If stock stays at $4.00-$4.25 after 2-3 trading days, the wide spread is real (not lag).

Near-term (30-60 days):

  1. Proxy filing - Detailed fairness opinion, management projections, board process
  2. Shareholder lawsuits - Expect filings arguing price inadequacy
  3. ISS/Glass Lewis - Proxy advisors' recommendations on deal
  4. Shareholder composition - Who holds the unaffiliated 58%? Retail vs institutions matters.

Medium-term (60-180 days):

  1. Stockholder vote - Majority of unaffiliated shares must approve (condition ii)
  2. HSR clearance - Antitrust (routine, low risk)
  3. Superior proposals - Any topping bids? (unlikely but possible)

THESIS DECISION TREE

If stock gaps to $5.40+ (spread <10%):

  • Market believes deal closes with high probability
  • Arb opportunity compressed
  • Pass unless you have differentiated view on close probability

If stock stays $4.00-$4.50 (spread 25-45%):

  • Market pricing 40-47% minority rejection risk
  • Fat arb if you believe Special Committee process is credible
  • Position size to survive deal break (not EV-maximizing size)
  • The dual-vote structure HELPS (condition i nearly guaranteed)

If stock falls below $4.00:

  • Market thinks deal breaks
  • Either (a) you see something market doesn't, or (b) pass

EDGE ASSESSMENT

Where could you have edge?

✗ Deal mechanics - Financing committed, dual-vote structure is standard. No edge here.

✗ Legal framework - Kahn v. MFW is well-understood. No edge here.

? Minority shareholder composition - Who are the unaffiliated holders? Retail (likely approve) vs activists (may fight)? Edge if you can map shareholder base.

? Fairness opinion details - Proxy will reveal Moelis assumptions. Edge if you can critique valuation methodology before vote.

? Operational trajectory - Is the 101% avg earnings beat sustainable? If yes, strengthens reject case. If no, deal price is fair.

? Superior proposal probability - Is there another buyer? Edge if you know industry M&A dynamics (franchise retail, PE appetite).

✓ Dual-vote math - Most observers miss that GA's 42% makes condition (i) nearly free. Risk concentrates in condition (ii). If market is pricing "general deal risk" instead of "minority-specific risk", spread is too wide.

This is NOT a "free money" arb. But the dual-vote structure materially reduces risk vs what the 45% spread implies.

POSITION FRAMING

This is a catalyst-dependent probability bet, not a value investment.

You are betting:

  • P(majority-of-minority approves) > market's implied ≈53-63%
  • The first voting hurdle (majority of all shares) passes easily (GA's 42% + 8% = 50.1%)
  • No superior proposal emerges
  • GA doesn't walk (reverse fee covers this risk)

You are NOT betting:

  • EWCZ standalone value (irrelevant if deal closes)
  • Operational performance (only matters if affects vote outcome)

Sizing principle:

  • Size for surviving wrong
  • 10th percentile path: deal breaks, stock $3.00
  • Can you afford -25% on position size X?

If answer is no, size smaller.

The dual-vote insight: Because GA's 42% nearly guarantees condition (i) passes, you're only betting on condition (ii). This is a cleaner, more concentrated risk than a single-vote MOM deal where everything hinges on one approval.

NUMBERS

  • Stock: $4.00
  • Deal: $5.80
  • Spread: 45%
  • Market cap: $218M (at $4.00)
  • Implied equity value: $330M (at $5.80)
  • Company fee: $6.6M (2% of deal value)
  • Reverse fee: $19M (5.8% of deal value)
  • Close timeline: ≈6 months
  • Annualized return if closes: ≈90%
  • GA ownership: ≈42% (votes on condition i, excluded from condition ii)
  • Condition (i) hurdle: 50.1% of all shares (GA has 42%, need 8% more)
  • Condition (ii) hurdle: >29% of all shares (>50% of unaffiliated 58%)

VERDICT

This is a time-sensitive merger arb setup with dual-vote structure that concentrates all risk in the minority approval vote.

Key insight: GA's 42% stake nearly guarantees the first voting hurdle passes. The entire 45% spread is pricing minority rejection risk on the second vote. If you believe Special Committee process was credible and minorities approve at >70% rate (vs market's implied ≈53-63%), this is positive EV.

NOT a buy recommendation - you need conviction that minority rejection probability is <30% (market prices ≈40-47%).

Action items:

  1. Monitor price action Feb 10-12 to see if spread compresses (market lag) or persists (real risk)
  2. When proxy drops, analyze:
    • Fairness opinion methodology and assumptions
    • Shareholder composition (who holds the unaffiliated 58%?)
    • Management projections vs actual performance
  3. Track any lawsuits challenging price adequacy
  4. If spread >15% persists after 3 trading days, consider position sized for deal-break survival

The opportunity: Market may be mispricing this as "general deal risk" when the dual-vote structure concentrates risk in one clean question: Will minorities approve? If you believe yes at >70%, the 45% spread is too wide.

The risk: Minority shareholders reject (40-47% market-implied probability), stock returns to $3-4 range, you lose 0-25%.

Size accordingly. The math favors the arb if you trust the Special Committee process.